1
|
Lombard FW and Mathew JP: Neurocognitive
dysfunction following cardiac surgery. Semin Cardiothorac Vasc
Anesth. 14:102–110. 2010. View Article : Google Scholar : PubMed/NCBI
|
2
|
McKhann GM, Grega MA, Borowicz LM Jr,
Baumgartner WA and Selnes OA: Stroke and encephalopathy after
cardiac surgery. An update Stroke. 37:562–571. 2006. View Article : Google Scholar
|
3
|
Mei B: Study of brain injury and brain
protection during cardiopulmonary bypass progress. Zhong Guo Ti Wai
Xun Huan Za Zhi. 8:125–127. 2010.In Chinese.
|
4
|
Bowen KK, Naylor M and Vemuganti R:
Prevention of inflammation is a mechanism of
preconditioning-induced neuro-protection against focal cerebral
ischemia. Neurochem Int. 49:127–135. 2006. View Article : Google Scholar : PubMed/NCBI
|
5
|
Pradillo JM, Fernández-López D,
García-Yébenes I, Sobrado M, Hurtado O, Moro MA and Lizasoain I:
Toll-like receptor 4 is involved in neuroprotection afforded by
ischemic preconditioning. J Neurochem. 109:287–294. 2009.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Broad A, Kirby JA and Jones DE; Applied
Immunology and Transplantation Research Group: Toll-like receptor
interactions: Tolerance of MyD88-dependent cytokines but
enhancement of MyD88-independent interferon-beta production.
Immunology. 120:103–111. 2007. View Article : Google Scholar
|
7
|
Marsh B, Stevens SL, Packard AE, Gopalan
B, Hunter B, Leung PY, Harrington CA and Stenzel-Poore MP: Systemic
lipopolysaccharide protects the brain from ischemic injury by
reprogramming the response of the brain to stroke: A critical role
for IRF3. J Neurosci. 29:9839–9849. 2009. View Article : Google Scholar : PubMed/NCBI
|
8
|
Marsh BJ and Stenzel-Poore MP: Toll-like
receptors: Novel pharmacological targets for the treatment of
neurological diseases. Curr Opin Pharmacol. 8:8–13. 2008.
View Article : Google Scholar
|
9
|
De Miranda J, Yaddanapudi K, Hornig M,
Villar G, Serge R and Lipkin WI: Induction of Toll-like receptor
3-mediated immunity during gestation inhibits cortical neurogenesis
and causes behavioral disturbances. MBio. 1:e00176–10. 2010.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Bsibsi M, Persoon-Deen C, Verwer RW,
Meeuwsen S, Ravid R and Van Noort JM: Toll-like receptor 3 on adult
human astrocytes triggers production of neuroprotective mediators.
Glia. 53:688–695. 2006. View Article : Google Scholar : PubMed/NCBI
|
11
|
Pan LN, Zhu W, Li C, Xu XL, Guo LJ and Lu
Q: Toll-like receptor 3 agonist Poly I:C protects against simulated
cerebral ischemia in vitro and in vivo. Acta Pharmacol Sin.
33:1246–1253. 2012. View Article : Google Scholar : PubMed/NCBI
|
12
|
Djaiani G, Fedorko L, Borger MA, Green R,
Carroll J, Marcon M and Karski J: Continuous-flow cell saver
reduces cognitive decline in elderly patients after coronary bypass
surgery. Circulation. 116:1888–1895. 2007. View Article : Google Scholar
|
13
|
Yan YG, Wang DJ, Wu Z, Li QZ and Zhou Q:
Relevant factors for severe neurological complications after
coronary artery bypass graft. Zhong Guo Zu Zhi Gong Cheng Yan Jiu.
14:1174–1178. 2010.In Chinese.
|
14
|
Anttila V, Hagino I, Iwata Y, Mettler BA,
Lidov HG, Zurakowski D and Jonas RA: Aprotinin improves cerebral
protection: Evidence from a survival porcine model. J Thorac
Cardiovasc Surg. 132:948–953. 2006. View Article : Google Scholar : PubMed/NCBI
|
15
|
Elefteriades JA: What is the best method
for brain protection in surgery of the aortic arch? Straight DHCA.
Cardiol Clin. 28:381–387. 2010. View Article : Google Scholar : PubMed/NCBI
|
16
|
Nelson DP, Andropoulos DB and Fraser CD
Jr: Perioperative neuroprotective strategies. Semin Thorac
Cardiovasc Surg Pediatr Card Surg Annu. 11:49–56. 2008. View Article : Google Scholar
|
17
|
Head BP and Patel P: Anesthetics and brain
protection. Curr Opin Anesthesiol. 20:395–399. 2007. View Article : Google Scholar
|
18
|
Xiong L, Zheng Y, Wu M, Hou L, Zhu Z,
Zhang X and Lu Z: Preconditioning with isoflurane produces
dose-dependent neuro-protection via activation of adenosine
triphosphate-regulated potassium channels after focal cerebral
ischemia in rats. Anesth Analg. 96:233–237. 2003.
|
19
|
Kitagawa K, Matsumoto M, Tagaya M, Hata R,
Ueda H, Niinobe M, Handa N, Fukunaga R, Kimura K and Mikoshiba K:
'Ischemic tolerance' phenomenon found in the brain. Brain Res.
528:21–24. 1990. View Article : Google Scholar : PubMed/NCBI
|
20
|
Yang Q, Dong H, Deng J, Wang Q, Ye R, Li
X, Hu S, Dong H and Xiong L: Sevoflurane preconditioning induces
neuroprotection through reactive oxygen species-mediated
up-regulation of antioxidant enzymes in rats. Anesth Analg.
112:931–937. 2011. View Article : Google Scholar : PubMed/NCBI
|
21
|
Wang J, Lei B, Popp S, Meng F, Cottrell JE
and Kass IS: Sevoflurane immediate preconditioning alters hypoxic
membrane potential changes in rat hippocampal slices and improves
recovery of CA1 pyramidal cells after hypoxia and global cerebral
ischemia. Neuroscience. 145:1097–1107. 2007. View Article : Google Scholar : PubMed/NCBI
|
22
|
Payne RS, Akca O, Roewer N, Schurr A and
Kehl F: Sevoflurane-induced preconditioning protects against
cerebral ischemic neuronal damage in rats. Brain Res. 1034:147–152.
2005. View Article : Google Scholar : PubMed/NCBI
|
23
|
Park HP, Jeong EJ, Kim MH, Hwang JW, Lim
YJ, Min SW, Kim CS and Jeon YT: Effects of sevoflurane on neuronal
cell damage after severe cerebral ischemia in rats. Korean J
Anesthesiol. 61:327–331. 2011. View Article : Google Scholar : PubMed/NCBI
|
24
|
Dabrowski W, Rzecki Z, Czajkowski M, Pilat
J, Wacinski P, Kotlinska E, Sztanke M, Sztanke K, Stazka K and
Pasternak K: Volatile anesthetics reduce biochemical markers of
brain injury and brain magnesium disorders in patients undergoing
coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth.
26:395–402. 2012. View Article : Google Scholar
|
25
|
Wang H, Lu S, Yu Q, Liang W, Gao H, Li P,
Gan Y, Chen J and Gao Y: Sevoflurane preconditioning confers
neuroprotection via anti-inflammatory effect. Front Biosci (Elite
Ed). 3:604–615. 2011. View
Article : Google Scholar
|
26
|
Song DD, Gao GJ, Sun YJ, Zhang TZ, Zhou J,
Zhang Y and Yao Q: Rats without blood prefilled established model
of cardiopulmonary bypass with cardiac arrest. Zhong Guo Ti Wai Xun
Huan Za Zhi. 4:232–235. 2009.In Chinese.
|
27
|
Obal D, Preckel B, Scharbatke H,
Müllenheim J, Höterkes F, Thämer V and Schlack W: One MAC of
sevoflurane provides protection against reperfusion injury in the
rat heart in vivo. Br J Anaesth. 87:905–911. 2001. View Article : Google Scholar
|
28
|
Payne RS, Akca O, Roewer N, Schurr A and
Kehl F: Sevoflurane-induced preconditioning protects against
cerebral ischemic neuronal damage in rats. Brain Res. 1034:147–152.
2005. View Article : Google Scholar : PubMed/NCBI
|
29
|
Hu X, Zhang Y, Li W, Liu J and Li Y:
Preconditioning with sevoflurane ameliorates spatial learning and
memory deficit after focal cerebral ischemia-reperfusion in rats.
Int J Dev Neurosci. 31:328–333. 2013. View Article : Google Scholar : PubMed/NCBI
|
30
|
Groom RC, Quinn RD, Lennon P, Welch J,
Kramer RS, Ross CS, Beaulieu PA, Brown JR, Malenka DJ, O'Connor GT,
et al: Microemboli from cardiopulmonary bypass are associated with
a serum marker of brain injury. J Extra Corpor Technol. 42:40–44.
2010.PubMed/NCBI
|
31
|
Herrmann M, Ebert AD, Galazky I,
Wunderlich MT, Kunz WS and Huth C: Neurobehavioral outcome
prediction after cardiac surgery role of neurobiochemical markers
of damage to neuronal and glial brain tissue. Stroke. 31:645–650.
2000. View Article : Google Scholar : PubMed/NCBI
|
32
|
Aly WW, Abdul-Rahman SA, El Said SMS, et
al: S100B and delirium in the geriatric acute care setting. Adv
Aging Res. 3:1–5. 2014. View Article : Google Scholar
|
33
|
Singh SP, Kapoor PM, Chowdhury U and Kiran
U: Comparison of S100β levels and their correlation with
hemodynamic indices in patients undergoing coronary artery bypass
grafting with three different anesthetic techniques. Ann Card
Anaesth. 14:197–202. 2011. View Article : Google Scholar : PubMed/NCBI
|
34
|
Nikolakopoulou Z, Smith M, Hector LR, et
al: S100A12 as a biomarker for neutrophil mediated inflammation in
patients undergoing cardiac surgery necessitating cardiopulmonary
bypass. Thorax. 68:141. 2013. View Article : Google Scholar
|
35
|
Song J, Park J, Kim JY, Kim JD, Kang WS,
Muhammad HB, Kwon MY, Kim SH, Yoon TG, Kim TY and Chung JW: Effect
of ulinastatin on perioperative function and systemic inflammatory
reaction during cardiac suregry: A randomized double-blinded study.
Korean J Anesthesiol. 64:334–340. 2013. View Article : Google Scholar : PubMed/NCBI
|
36
|
Li W, Wu X, Yan F, Liu J, Tang Y, Ma K and
Li S: Effects of pulmonary artery perfusion with urinary trypsin
inhibitor as a lung protective strategy under hypothermic low-flow
cardiopulmonary bypass in an infant piglet model. Perfusion.
29:434–442. 2014. View Article : Google Scholar
|
37
|
Liu XQ, Sheng R and Qin ZH: The
neuroprotective mechanism of brain ischemic preconditioning. Acta
Pharmacol Sin. 30:1071–1080. 2009. View Article : Google Scholar : PubMed/NCBI
|
38
|
Lakhan SE, Kirchgessner A and Hofer M:
Inflammatory mechanisms in ischemic stroke: Therapeutic approaches.
J Transl Med. 7:972009. View Article : Google Scholar : PubMed/NCBI
|
39
|
Ramlawi B, Rudolph JL, Mieno S, Feng J,
Boodhwani M, Khabbaz K, Levkoff SE, Marcantonio ER, Bianchi C and
Sellke FW: C-Reactive protein and inflammatory response associated
to neurocognitive decline following cardiac surgery. Surgery.
140:221–226. 2006. View Article : Google Scholar : PubMed/NCBI
|
40
|
Ashraf S, Bhattacharya K, Tian Y and
Watterson K: Cytokine and S100B levels in paediatric patients
undergoing corrective cardiac surgery with or without total
circulatory arrest. Eur J Cardiothorac Surg. 16:32–37. 1999.
View Article : Google Scholar : PubMed/NCBI
|
41
|
Vila N, Castillo J, Dávalos A and Chamorro
A: Proinflammatory cytokines and early neurological worsening in
ischemic stroke. Stroke. 31:2325–2329. 2000. View Article : Google Scholar : PubMed/NCBI
|
42
|
Selzner N, Selzner M, Odermatt B, Tian Y,
Van Rooijen N and Clavien PA: ICAM-1 triggers liver regeneration
through leukocyte recruitment and Kupffer cell-dependent release of
TNF-alpha/IL-6 in mice. Gastroenterology. 124:692–700. 2003.
View Article : Google Scholar : PubMed/NCBI
|
43
|
Liu ZM, Yang QD, Liu YH, Huang XS and
Zhang N: Serum IL-6 in patients with cerebral infarction and
SICAM-1 and its clinical significance. Zhong Nan Da Xue Xue Bao Yi
Xue Ban. 29:326–329. 2004.In Chinese.
|
44
|
Reinsfelt B, Ricksten SE, Zetterberg H,
Blennow K, Fredén-Lindqvist J and Westerlind A: Cerebrospinal fluid
markers of brain injury, inflammation and blood-brain barrier
dysfunction in cardiac surgery. Ann Thorac Surg. 94:549–555. 2012.
View Article : Google Scholar : PubMed/NCBI
|
45
|
Lee SH, Kim BJ, Kim YB, Chung PW, Moon HS,
Suh BC, Yoon WT, Jin DK, Park YS, Lee YT and Park KY: IL-1β
induction and IL-6 suppression are associated with aggravated
neuronal damage in a lipopolysaccharide-pretreated kainic
acid-induced rat pup seizure model. Neuroimmunomodulation.
19:319–325. 2012. View Article : Google Scholar
|
46
|
Bedirli N, Bagriacik EU, Emmez H, Yilmaz
G, Unal Y and Ozkose Z: Sevoflurane and isoflurane preconditioning
provides neuroprotection by inhibition of apoptosis-related mRNA
expression in a rat model of focal cerebral ischemia. J Neurosurg
Anesthesiol. 24:336–344. 2012. View Article : Google Scholar : PubMed/NCBI
|
47
|
Barreto G, White RE, Ouyang Y, Xu L and
Giffard RG: Astrocytes: Targets for neuroprotection in stroke. Cent
Nerv Syst Agents Med Chem. 11:164–173. 2011. View Article : Google Scholar : PubMed/NCBI
|
48
|
Rosenzweig HL, Lessov NS, Henshall DC,
Minami M, Simon RP and Stenzel-Poore MP: Endotoxin preconditioning
prevents cellular inflammatory response during ischemic
neuroprotection in mice. Stroke. 35:2576–2581. 2004. View Article : Google Scholar : PubMed/NCBI
|
49
|
Nhu QM, Cuesta N and Vogel SN:
Transcriptional regulation of lipopolysaccharide (LPS) -induced
toll-like receptor (TLR) expression in murine macrophages: Role of
interferon regulatory factors 1 (IRF-1) and 2 (IRF-2). J Endotoxin
Res. 12:285–295. 2006. View Article : Google Scholar
|